LexaGene Life Sciences

LexaGene Holdings, Inc. was founded by Dr. Jack Regan in October of 2016. Prior to founding LexaGene Holdings Inc., Dr. Regan developed instruments for bio-warfare surveillance and respiratory pathogen detection. LexaGene developed the MiQLab® System, which is a fully automated sample-to-answer PCR system for rapidly detecting and characterizing microbes. The original market focus of LexaGene was companion animal veterinary bacterial diagnostics. Later in the company’s tenure, based on feedback from people that are in the biopharmaceutical manufacturing industry, management started exploring the use case of the technology to detect broader microbial contaminants that can negatively affect biopharmaceutical manufacturing. In June 2023, the largest equity holder of LexaGene Holdings, Inc. acquired the assets of the Company and executed a restructuring to form LexaGene Life Sciences. The new Company will carry on the original mission of LexaGene.